The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
NMDA receptor pathways as drug targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic enhancement of learning and memory in mice
Tang, Y.-P., Shimizu, E., Dube, G. R., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,863
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Proteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptor
Mothet, J.-P., Parent, A. T., Wolosker, H., Brady, R. O., Linden, D. J., Ferris, C. D., Rogawski, M. A., & Snyder, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4926 · Cited by 1,137
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Lu, W.-Y., Man, H.-Y., Ju, W., Trimble, W. S., MacDonald, J. F., & Wang, Y. T. (2001) · Neuron · doi:10.1016/s0896-6273(01)00194-5 · Cited by 910
Williams, K. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13275-6 · Cited by 853
Wolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811
Handbook of Experimental Pharmacology
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-1-269_2 · Cited by 727
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits
Chatterton, J. E., Awobuluyi, M., Premkumar, L. S., Takahashi, H., Talantova, M., Shin, Y., Cui, J., Tu, S., Sevarino, K. A., Nakanishi, N., et al. (2002) · Nature · doi:10.1038/nature715 · Cited by 694
D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia
Tsai, G. E., Yang, P., Chang, Y.-C., & Chong, M.-Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 674
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
Das, S., Sasaki, Y. F., Rothe, T., Premkumar, L. S., Takasu, M., Crandall, J. E., Dikkes, P., Conner, D. A., Rayudu, P. V., Cheung, W., et al. (1998) · Nature · doi:10.1038/30748 · Cited by 609
Drugs and the Pharmaceutical Sciences
(2010) · Drugs and the pharmaceutical sciences · doi:10.1201/ihcdruphasci · Cited by 586
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
D-serine added to antipsychotics for the treatment of schizophrenia
Tsai, G., Yang, P., Chung, L.-C., Lange, N., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 571
Schizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 385
Collingridge, G. L., & Watkins, J. C. (1995) · Medical Entomology and Zoology · Cited by 355
Boyce, S., Wyatt, A., Webb, J. K., O’Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R. G., & Rupniak, N. M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00218-4 · Cited by 342
The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential
Leeson, P. D., & Iversen, L. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a001 · Cited by 315
Drugs and the Pharmaceutical Sciences
Neubert, R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00002-4 · Cited by 311
Lees, K. R., Asplund, K., Carolei, A., Davis, S. M., Diener, H.-C., Kaste, M., Orgogozo, J.-M., & Whitehead, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02326-6 · Cited by 309
Sacco, R. L., DeRosa, J. T., Haley, Jr., Levin, B., Ordronneau, P., Phillips, S. J., Rundek, T., Snipes, R. G., Thompson, J. L. P., & for the GAIN Americas Investigators (2001) · JAMA · doi:10.1001/jama.285.13.1719 · Cited by 283
Kew, J. N., Trube, G., & Kemp, J. A. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021807 · Cited by 240
Self-citationGotti, B., Duverger, D., Bertin, J., Carter, C., Dupont, R., Frost, J., Gaudilliere, B., MacKenzie, E. T., Rousseau, J., & Scatton, B. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13281-3 · Cited by 240
Krystal, J. (1999) · Harvard Review of Psychiatry · doi:10.1093/hrp/7.3.125 · Cited by 232
NMDA receptors as targets for drug action in neuropathic pain
Parsons, C. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01307-3 · Cited by 226
NMDA receptor antagonists as analgesics: focus on the NR2B subtype
Chizh, B. A., Headley, P. M., & Tzschentke, T. M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01863-0 · Cited by 209
NMDA receptor antagonists can enhance or impair learning performance in animals
Mondadori, C., Weiskrantz, L., Buerki, H., Petschke, F., & Fagg, G. E. (1989) · Experimental Brain Research · doi:10.1007/bf00249896 · Cited by 185
Mapping the Binding Site of the Neuroprotectant Ifenprodil on NMDA Receptors
Perin-Dureau, F., Rachline, J., Neyton, J., & Paoletti, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05955.2002 · Cited by 183
Malayev, A., Gibbs, T. T., & Farb, D. H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704543 · Cited by 176
Heresco-Levy, U., Ermilov, M., Shimoni, J., Shapira, B., Silipo, G., & Javitt, D. C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.480 · Cited by 167
Davis, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02138.x · Cited by 164
Dotto, P. D., Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N., & Bonuccelli, U. (2001) · Movement Disorders · doi:10.1002/mds.1112 · Cited by 153
Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms
Chase, T. N., Oh, J. D., & Konitsiotis, S. (2000) · Journal of Neurology · doi:10.1007/pl00007759 · Cited by 122
The postsynaptic NMDA-receptor–PSD-95 signaling complex in excitatory synapses of the brain
Sheng, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1251 · Cited by 84
Gill, R., Alanine, A. I., Bourson, A., Büttelmann, B., Fischer, G., Heitz, M., Kew, J. N. C., Levet‐Trafit, B., Lorez, H. P., Malherbe, P., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034322 · Cited by 51
Self-citationFacilitation of social learning by treatment with an NMDA receptor antagonist
Lederer, R., Radeke, E., & Mondadori, C. (1993) · Behavioral and Neural Biology · doi:10.1016/0163-1047(93)90409-b · Cited by 19
Glycine-site antagonists and stroke
Tranquillini, M. E., & Reggiani, A. M. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.11.1837 · Cited by 17
Cited by
Animal models of pain: progress and challenges
Mogil, J. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2606 · Cited by 1,120
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
Self-citationLiu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0116-07.2007 · Cited by 773
Metadata
- Authors
- Kemp, J. A., & McKernan, R. M.
- Venue
- Nature Neuroscience
- Published
- 2002-10-28
- Volume
- 5
- Issue
- S11
- Pages
- 1039-1042
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2085912953
- Cited by
- 476
- References
- 38
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.